BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 3390844)

  • 21. Abnormalities of the genital tract following stilbestrol exposure in utero.
    Kurman RJ
    Recent Results Cancer Res; 1979; 66():161-74. PubMed ID: 373028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genital clear cell adenocarcinoma.
    Johnston GA; Jones HA
    Int Surg; 1983; 68(3):257-61. PubMed ID: 6662641
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epidemiological studies of the effects of diethylstilboestrol.
    Vessey MP
    IARC Sci Publ; 1989; (96):335-48. PubMed ID: 2680951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vaginal adenosis and diethylstilboestrol.
    Emens M
    Br J Hosp Med; 1984 Jan; 31(1):42-8. PubMed ID: 6697040
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinicopathologic study of vagina and cervix in DES-exposed progeny.
    Zerner J; Fu YS; Taxiarchis LN; Reagan JW; Richart RM
    Diagn Gynecol Obstet; 1980; 2(4):245-56. PubMed ID: 7215109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of in utero diethylstilbestrol exposure on the prognosis and biologic behavior of vaginal clear-cell adenocarcinoma.
    Waggoner SE; Mittendorf R; Biney N; Anderson D; Herbst AL
    Gynecol Oncol; 1994 Nov; 55(2):238-44. PubMed ID: 7959291
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intrauterine diethylstilbestrol exposure and its consequences: pathologic characteristics of vaginal adenosis, clear cell adenocarcinoma, and related lesions.
    Robboy SJ; Scully RE; Welch WR; Herbst AL
    Arch Pathol Lab Med; 1977 Jan; 101(1):1-5. PubMed ID: 576195
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DES clinic--the first six months.
    Wingfield M; Donnelly VS; Kelehan P; Stronge JM; Murphy J; Boylan P
    Ir Med J; 1992 Jun; 85(2):56-8. PubMed ID: 1628942
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Refocusing on the gynecological and obstetrical consequences of intrauterine exposure to diethylstilbestrol (DES)].
    Verheijen RH; Schijf CP; van Dongen PW; van der Zanden PH; Bakker EH
    Ned Tijdschr Geneeskd; 1991 Jan; 135(3):89-93. PubMed ID: 1996166
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A case of vaginal adenocarcinoma after uterine exposure to diethylstilbestrol].
    Schreiner WE; Bronz L; Wyss-Bernet M; Genton CY
    Schweiz Med Wochenschr; 1985 Nov; 115(44):1555-61. PubMed ID: 3841230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diethylstilbestrol in pregnancy: an update.
    Kinch RA
    Can Med Assoc J; 1982 Nov; 127(9):812-3. PubMed ID: 7139494
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of histologic and colposcopic findings in DES-exposed females.
    Welch WR; Robboy SJ; Townsend DE; Barnes AB; Scully RE; Herbst AL
    Obstet Gynecol; 1978 Oct; 52(4):457-61. PubMed ID: 714329
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal and cervical cancers and other abnormalities associated with exposure in utero to diethylstilbestrol and related synthetic hormones.
    J Fla Med Assoc; 1977 Feb; 64(2):96-8. PubMed ID: 839195
    [No Abstract]   [Full Text] [Related]  

  • 34. Rates and risks of diethylstilbestrol-related clear-cell adenocarcinoma of the vagina and cervix. An update.
    Melnick S; Cole P; Anderson D; Herbst A
    N Engl J Med; 1987 Feb; 316(9):514-6. PubMed ID: 3807995
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clear-cell adenocarcinoma of the lower genital tract: Memorial Hospital 1974-1984.
    Jones WB; Koulos JP; Saigo PE; Lewis JL
    Obstet Gynecol; 1987 Oct; 70(4):573-7. PubMed ID: 3627626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors associated with a lack of pap smear utilization in women exposed in utero to diethylstilbestrol.
    Camp EA; Prehn AW; Shen J; Herbst AL; Strohsnitter WC; Hobday CD; Robboy SJ; Adam E
    J Womens Health (Larchmt); 2015 Apr; 24(4):308-15. PubMed ID: 25768943
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaginal and cervical cancers associated with exposure in utero to diethylstilbestrol.
    J Tenn Med Assoc; 1977 May; 70(5):340-2. PubMed ID: 865116
    [No Abstract]   [Full Text] [Related]  

  • 38. In utero exposure to DES. Evaluation and followup of 199 women.
    Fowler WC; Edelman DA
    Obstet Gynecol; 1978 Apr; 51(4):459-63. PubMed ID: 662229
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diethylstilbestrol and other sex hormones during pregnancy.
    Herbst AL
    Obstet Gynecol; 1981 Nov; 58(5 Suppl):35S-40S. PubMed ID: 7031540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Elevated serum cathepsin B1 and vaginal pathology after prenatal DES exposure.
    Pietras RJ; Szego CM; Mangan CE; Seeler BJ; Burtnett MM; Orevi M
    Obstet Gynecol; 1978 Sep; 52(3):321-7. PubMed ID: 703988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.